Accili, Domenico http://orcid.org/0000-0002-6874-3949
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (57539, 58282, 64819)
Article History
First Online: 11 January 2021
Competing interests
: D.A. reports no conflicts of interest influencing the content of this Comment. He is a founder, director and chair of the board of advisors of Forkhead BioTherapeutics Corp. He also serves on the Global Diabetes Advisory Board for Eli Lilly and Co.
Free to read: This content has been made available to all.